Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for OMALIZUMAB
- Dose Escalation Trial Of Safety, Pharmacokinetic/Pharmacodynamic And Preliminary Clinical Activity of Briquilimab In Adult Patients With Chronic Spontaneous Urticaria (CSU)
- E-B-FAHF-2, Multi OIT and Xolair for Food Allergy
- A Phase 3b Study to Assess the Efficacy, Safety, and Tolerability of Remibrutinib in Comparison to Placebo and With Omalizumab as Active Control in CSU Adult Patients.
- A Single Dose, Phase 1 Study of YH35324 in Patients With Various Allergic Diseases
- Study to Compare Efficacy Safety and Immunogenicity of ADL-018 With XOLAIR (Omalizumab) in Adults With Chronic Idiopathic Urticaria
- A Multiple Ascending Dose, Phase 1b Study of YH35324 in Atopic Healthy Subjects or Subjects With Mild Allergic Diseases
- Study of JYB1904 (an Anti-immunoglobulin E Antibody) in Healthy Chinese Subjects
- Omalizumab Efficacy in Patients With Refractory Nasal Polyps
- Establishment of Precise Diagnosis and Treatment System for Refractory Chronic Rhinosinusitis
- Omalizumab Before Onset of Exacerbations
- A Prospective Study on Optimizing Treatment for ABPA
- Rilzabrutinib for the Treatment of Chronic Spontaneous Urticaria in Patients Who Remain Symptomatic Despite the Use of H1 Antihistamine and Who Are naïve to Omalizumab
- A FIH Study of YH35324 in Atopic Healthy Subjects or Subjects With Mild Allergic Diseases
- Biosimilar Study Comparing PK, PD, Safety and Immunogencity of BP11 With US Licensed Xolair and EU Approved Xolair
- Mechanisms of Dupilumab in AERD
- EValuating trEatment RESponses of Dupilumab Versus Omalizumab in Type 2 Patients
- Evaluate the Safety, Tolerability, Pharmacodynamics, and Efficacy of CNP-201 in Subjects Ages 16-55 With Peanut Allergy
- The Study of Omalizumab (CMAB007 and Xolair) in Healthy Subjects to Compare the PK, PD and Safety
- Molecular Endotypes of Chronic Idiopathic Urticaria
- Short Treatment With Omalizumab for Severe Asthma
- Comparing Treatment Efficacy With Mepolizumab and Omalizumab in Severe Asthma - "Choosebetweenamab".
- Xolair Interventional Study in ASD Patients With Comorbid Atopy
- The Efficacy of Preseasonal Omalizumab Treatment
- Viral Infection in Asthma (VIA) Study
- Comparison of Pharmacokinetics and Safety of HS632 and Xolair® With a Single Injection
- A Pragmatic Study to Investigate the Efficacy and Safety of Mepolizumab in Severe Uncontrolled Asthma in Brazil
- A Study to Assess the Impact of Omalizumab on Exercise Capacity, Physical Activity, and Sleep Quality in Participants With Moderate to Severe Allergic Asthma
- Dupilumab for the Treatment of Chronic Spontaneous Urticaria in Patients Who Remain Symptomatic Despite the Use of H1 Antihistamine and Who Are naïve to, Intolerant of, or Incomplete Responders to Omalizumab
- Efficacy and Safety of Rituximab Combined With Omalizumab in Patients With Bullous Pemphigoid
- Behandling af Boern Med Foedevareallergi Med Omalizumab (Xolair)
- Protection From Food Induced Anaphylaxis by Reducing the Serum Level of Specific IgE (Protana).
- Omalizumab as Monotherapy and as Adjunct Therapy to Multi-Allergen OIT in Food Allergic Participants
- Tranexamic Acid and Spontaneous Chronic Urticaria
- Cholinergic Urticaria - Efficacy of Dupilumab
- Dupilumab in Chronic Spontaneous Urticaria
- Treatment With the Anti-IgE Monoclonal Antibody Omalizumab in Women With Asthma Undergoing Fertility Treatment. - A Proof of Concept Study.
- Clinical Study Using Biologics to Improve Multi OIT Outcomes
- An Extension Study of Omalizumab in Participants With Chronic Rhinosinusitis With Nasal Polyps
- Study of Magnitude and Prediction of Response to Omalizumab and Mepolizumab in Adult Severe Asthma.
- Benralizumab Effect on Severe Chronic Rhinosinusitis With Eosinophilic Polyposis
- Study of Efficacy and Safety of Omalizumab in Severe Japanese Cedar Pollinosis Adult and Adolescent Patients
- Study of Efficacy and Safety of Xolair® (Omalizumab) in Chinese Patients With Chronic Spontaneous Urticaria
- A Clinical Trial of Omalizumab in Participants With Chronic Rhinosinusitis With Nasal Polyps
- A Clinical Trial of Omalizumab in Participants With Chronic Rhinosinusitus With Nasal Polyps
- Multi OIT to Test Immune Markers After Minimum Maintenance Dose
- A Study Evaluating Vitamin D in Allergic Bronchopulmonary Aspergillosis Complicating Asthma
- Role of Immunoglobulin E (IgE) Bearing Cells in Chronic Idiopathic Urticaria (CIU)
- Reslizumab in Patients With Severe Asthma Who Failed to Respond to Omalizumab
- Effect of Intranasal Anti-IgE Antibodies on IgE Production
- Omalizumab Treatment in Venom Immunotherapy With Systemic Reactions
- Treatment of Idiopathic Angioedema With Xolair as Add-on Therapy
- E-B-FAHF-2, Multi OIT and Xolair (Omalizumab) for Food Allergy
- Sustained Effect of Urticaria Remission With Relatively High Dose Vitamin D Supplementation After Omalizumab Discontinuation
- Sputum-derived Cellular Targets After Xolair (Omalizumab)
- Omalizumab to Mepolizumab Switch Study in Severe Eosinophilic Asthma Patients
- Study Using Xolair in Rush Multi Oral Immunotherapy in Multi Food Allergic Patients
- Multi Immunotherapy to Test Tolerance and Xolair
- Preventing Asthma in High Risk Kids
- Omalizumab in Chronic Spontaneous Urticaria Patients Non Responding to Initial Standard antihistaminE Treatment
- Treatment of Severe Peanut Allergy With Xolair (Omalizumab) and Oral Immunotherapy
- A Study of the Efficacy and Safety of Omalizumab Through 48 Weeks in Participants With Chronic Idiopathic Urticaria
- Treatment With Omalizumab to Improve the Asthmatic Response to Rhinovirus Experimental Infection With Rhinovirus
- Role of Anti-IgE in Severe Childhood Eczema
- Cross-sectional Study for Identification and Description of Severe Asthma Patients
- Role of Omalizumab in Reducing the Incidence of Oxaliplatin-induced Hypersensitivity Reaction
- Omalizumab in Severe and Refractory Solar Urticaria
- Efficacy and Safety of Omalizumab in Patients With Severe Acute Urticaria
- Urticaria Facticia Treatment With Omalizumab (UFO)
- Efficacy and Safety of Omalizumab in Chronic Idiopathic Urticaria
- OPTIMA: Efficacy of Optimized Re-treatment and Step-up Therapy With Omalizumab in Chronic Spontaneous Urticaria (CSU) Patients
- Low-dose Methotrexate for Change in Global Initiative for Asthma Step 5 Medications in Chronic Severe Asthma
- Study of Omalizumab as Adjuvant Therapy in Chemotherapy Desensitization
- Study of the Steroid Sparing Effect of Xolair (Omalizumab) in Patients With Persistent Eosinophilic Bronchitis
- Predicting the Clinical Response to Omalizumab With Anti-Immunoglobulin E (IgE) Ab Response or Syk Expression in Basophils
- Safety and Efficacy Study of Omalizumab to Treat Allergic Asthma
- A Study in Participants With Asthma Initiating Treatment With Omalizumab (Xolair)
- Study to Assess the Efficacy and Safety of Omalizumab Treatment on ICS Reduction for Severe IgE-mediated Asthma
- Xolair (Omalizumab) for Treatment of Drug-induced Acute Tubulointerstitial Nephritis (AIN)
- Prospective Double-blind Placebo-controlled Study of the Effect of Xolair (Omalizumab) in Chronic Urticaria Patients
- Peanut Reactivity Reduced by Oral Tolerance in an Anti-IgE Clinical Trial
- Impact of Omalizumab on Quality of Life Measures and Angioedema Occurrence in Patients With CSU Refractory to Therapy
- Efficacy and Safety of QGE031versus Placebo and Omalizumab in Patients Aged 18-75 Years With Asthma
- Omalizumab for Lupus
- A Study Evaluating the Efficacy of QGE031 Compared to Omalizumab in Patients With Allergic Asthma
- Effect of Omalizumab (Xolair) on Basophils in Patients With Chronic Idiopathic Urticaria
- Mode of Action Study of Omalizumab in Patients With Chronic Idiopathic Urticaria (CIU) Who Fail to Respond to Antihistamine Treatment
- Cold Urticaria Treatment With Xolair
- The Use of FKBP51 in the Identification of Non-adherence to Inhaled Corticosteroids in Difficult Asthma
- Omalizumab With Oral Food Immunotherapy With Food Allergies Open Label Safety Study in a Single Center
- Preventative Omalizumab or Step-up Therapy for Severe Fall Exacerbations
- Clinical and Biological Effects of Anti-IgE (Omalizumab) in Patients With Bilateral Nasal Polyposis and Asthma
- The Effect of Xolair ® (Omalizumab) in Mastocytosis Patients
- Long-term Safety, Tolerability and Efficacy of Omalizumab in Japanese Children
- Omalizumab in Interstitial Cystitis/Bladder Pain Syndrome
- A Study to Evaluate the Efficacy, Response Duration and Safety of Xolair (Omalizumab) in Patients With Chronic Idiopathic Urticaria (CIU)/Chronic Spontaneous Urticaria (CSU) Who Remain Symptomatic Despite Antihistamine Treatment (H1)
- Xolair Enhances Oral Desensitization in Peanut Allergic Patients
- A Study of the Efficacy and Safety of Omalizumab (Xolair) in Patients With Chronic Idiopathic Urticaria (CIU)/Chronic Spontaneous Urticaria (CSU) Who Remain Symptomatic Despite Antihistamine (H1) Treatment
- A Safety Study of Xolair (Omalizumab) in Patients With Chronic Idiopathic Urticaria (CIU) Who Remain Symptomatic Despite Treatment With H1 Antihistamines, H2 Blockers, and/or Leukotriene Receptor Antagonists
- The Use of Fractional Exhaled Nitric Oxide in the Identification of Non-adherence in Difficult Asthma
- Omalizumab in Patients With Moderate to Severe Persistent Allergic Asthma Not Adequately Controlled Despite GINA (2009) Step 4 Therapy
- Atopic Dermatitis Biomarker Identification Trial in Omalizumab Usage
- OIT and Xolair® (Omalizumab) in Cow's Milk Allergy
- Pharmacokinetics and Pharmacodynamics, Efficacy and Safety of Omalizumab in Japanese Children (6 - 15 Years)
- A Study Evaluating the Persistency of Response With or Without Xolair (Omalizumab) After Long-term Therapy
- Omalizumab in Non-atopic Asthma
- Subcutaneous Omalizumab for Treatment of Chronic Rhinosinusitis With Nasal Polyposis
- Effect of Omalizumab in Patients With Severe Persistent Non-atopic Uncontrolled Asthma
- The Effects of Omalizumab (Anti-IgE) on the Late-phase Response to Nasal Allergen Challenge
- Xolair Treatment for Milk Allergic Children
- Omalizumab in the Treatment of Peanut Allergy
- Peanut Oral Immunotherapy and Anti-Immunoglobulin E (IgE) for Peanut Allergy
- A Randomized, Double-Blind, Placebo-Controlled Study of Omalizumab for Idiopathic Anaphylaxis
- Evaluate the Effect of Omalizumab on Markers of Asthma Impairment in Patients With Persistent Allergic Asthma
- A Study of Xolair (Omalizumab) in Patients With Chronic Idiopathic Urticaria (CIU) Who Remain Symptomatic With Antihistamine Treatment (H1)
- Exploratory Study of Xolair in Chronic Obstructive Pulmonary Disease in Patients With Elevated IgE Levels
- Study to Determine the Effect of an Anti-IgE Agent on Inflammatory Cells in the Skin of Atopic Dermatitis Patients
- An Exploratory Study to Assess Multiple Doses of Omalizumab in Patients With Cystic Fibrosis Complicated by Acute Bronchopulmonary Aspergillosis (ABPA)
- Non-invasive Measures of Effects of Xolair in Asthma
- The Safety and Utility of Skin Testing With XOLAIR® (Omalizumab) and Placebo Omalizumab (Formulation Excipients)
- Study to Evaluate the Effect of Xolair(Omalizumab) on Improving the Tolerability of Specific Immunotherapy in Patients With at Least Moderate Persistent Allergic Asthma Inadequately Controlled With Inhaled Corticosteroids
- Efficacy of Omalizumab in Adults (18-60 Years of Age) With Moderate-Severe, Persistent Allergic Asthma, Despite Receiving Inhaled Corticosteroids and Long Acting Beta-agonists
- The Effect of Xolair (Omalizumab) on Allergy Blood Cells
- The Effect of Omalizumab on Responses to Cat Allergen Challenge
- Effects of Anti-IgE Antibody Omalizumab on Patients With Chronic Sinusitis
- Omalizumab Use and Asthma-Related Quality of Life in Patients With Severe Persistent Allergic Asthma
- Therapeutic Utility of Xolair in Patients Undergoing Aspirin Desensitization
- Safety and Tolerability of Omalizumab in Patients With Mild to Moderate Asthma
- Open Label Study to Assess Safety and Immunogenicity of Omalizumab Liquid Formulation.
- A Study of Omalizumab in Preventing Bronchoconstriction Following Environmental Cat Dander Exposure in Patients With Cat Dander-induced Asthma
- Safety and Tolerability of Omalizumab in Poorly Controlled Moderate to Severe Asthma Patients
- Safety and Tolerability of Omalizumab in Adults and Adolescents With Severe Allergic Asthma
- Efficacy and Safety of Omalizumab in Adults (18-70 Years) With Moderate to Severe Chronic Urticaria
- Efficacy and Safety of Omalizumab in Bullous Pemphigoid
- Effect of Omalizumab on Expression of IgE Receptors in Adults With Severe, Inadequately Controlled Allergic Asthma
- A Study of Omalizumab in the Prevention of Allergen Induced Airway Obstruction in Adults With Mild Allergic Asthma
- Efficacy/ Safety of Omalizumab in Patients With Seasonal Allergic Asthma and Seasonal Allergic Rhinoconjunctivitis
- A Study of Xolair in Peanut-Allergic Subjects Previously Enrolled in Study Q2788g
- Immunologic Basis of Anti-IgE Therapy (Study II: On Patients With Asthma)
- Safety and Efficacy Study of Omalizumab Given Prior to Immunotherapy
- A Study of Omalizumab (Xolair) in Subjects With Moderate to Severe Persistent Asthma (EXTRA)
- Effect of Ozone on Airway Inflammation in Allergic Asthmatics Treated With Omalizumab
- Effect of Omalizumab (Xolair) in Treatment of Patients With AERD and Allergy Asthma
- Study to Evaluate the Effect of Omalizumab on Improving the Tolerability of Specific Immunotherapy in Patients With Persistent Allergic Asthma
- Omalizumab in Adult and Adolescent Patients With Severe Persistent Allergic Asthma
- Omalizumab to Treat Hyper-IgE (Job's) Syndrome
- A Pilot Study Investigating the Effect of Omalizumab (Xolair) in Work-Related Animal Induced Asthma
- Study of Omalizumab in Moderate to Severe Bronchial Asthma
- Soluble CD23 Expression in Asthma Patients Treated With OMA
- Long-Term Study of IGE025 in Moderate to Severe Bronchial Asthma.
- Effect of Xolair on Airway Hyperresponsiveness
- Efficacy of Omalizumab as Add on Therapy for Minority Patients With Moderate to Severe Asthma
- Effect of Anti-IgE in Non-Allergic Asthma
- Non-invasive Ways to Evaluate Lung Disease After Treatment With Xolair
- The Effect of Omalizumab on Airway Responsiveness to Adenosine in Patients With Poorly Controlled Asthma
- Effect of Anti-IgE in Chronic Urticaria
- A Pilot Study of the Treatment of Eosinophilic Esophagitis With Omalizumab
- Xolair in Patients With Chronic Sinusitis
- A Continued Access Protocol to Provide Xolair to Patients With Severe Allergic Asthma
- An Extension Study of Xolair in Moderate to Severe, Persistent Asthma Patients Who Completed Study Q2143g
- A Prospective, Randomized, Double-Blind Study of the Efficacy of Omalizumab (Xolair) in Atopic Asthmatics With Good Lung Capacity Who Remain Difficult to Treat (EXACT)
- A Safety and Efficacy Study of Xolair in Peanut Allergy
- Omalizumab to Treat Eosinophilic Gastroenteritis
- Efficacy and Safety of Omalizumab in Children (6 - < 12 Years) With Moderate-severe, Inadequately Controlled Allergic Asthma
- Efficacy and Safety of Omalizumab in Patients With Severe Persistent Asthma
Clinical trials list
click for details